| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that the equation t1/2 = VD / Cl * 0.693 was used | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| MOBOCERTINIB DISCONTINUED (has an active metabolite)
| MOBOCERTINIB | ANTINEOPLASTIC | ORAL | Tmax 4 HOUR F 37 PERCENT VD 3509 LITER PPB 99.3 PERCENT Cl 138 LITER / HOUR HT 18 HOUR SOLUBILITY 17 MILLIGRAM PER MILLILITER AT PH 6.8 | EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) (MUTATED) HER2 HER4 BLK | Epidermal growth factor receptor UNIPROT P00533 EGFR -- Receptor tyrosine-protein kinase erbB-2 UNIPROT P04626 ERBB2 more at DrugCentral | EMA | |||
